| Biological Information | |
|---|---|
| Background Information: | SB220025 is a synthetic small molecule, and a potent and selective inhibitor of the p38 mitogen-activated protein kinase (MAPK, IC50=60nM), 50-1000-fold selective over other MAP kinases. Potent inhibitor of angiogenesis, inflammatory cytokine production, and TNF-α production. Provided as 0.5 mg of dry powder. |
| Target Name: | SB220025 |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Room temperature. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
SB220025
SB220025 is an agonist for MAPK14. This product is provided as 0.5 mg of dry powder.
Datasheets
92-1241 Datasheet
View Document